Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report

BACKGROUND: Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recognized that they are associated with autoimmune or autoinflammatory side effects. These toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Fumi, Saheki, Takanobu, Imachi, Hitomi, Kobayashi, Toshihiro, Fukunaga, Kensaku, Ibata, Tomohiro, Sato, Seisuke, Ban, Natsuki, Lyu, Jingya, Japar, Salimah, Murao, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067320/
https://www.ncbi.nlm.nih.gov/pubmed/33892782
http://dx.doi.org/10.1186/s13256-020-02656-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067320/
https://www.ncbi.nlm.nih.gov/pubmed/33892782
http://dx.doi.org/10.1186/s13256-020-02656-7

Ejemplares similares